Stanley-Laman Group’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$242K Buy
1,094
+107
+11% +$29.6K 0.02% 283
2026
Q1
$292K Buy
+987
New +$293K 0.04% 256
2021
Q3
Sell
-10,461
Closed -$2.23M 257
2021
Q2
$2.23M Buy
10,461
+847
+9% +$179K 0.32% 94
2021
Q1
$1.96M Sell
9,614
-1,305
-12% -$257K 0.32% 93
2020
Q4
$1.99M Sell
10,919
-993
-8% -$169K 0.35% 74
2020
Q3
$1.99M Sell
11,912
-324
-3% -$54.6K 0.44% 56
2020
Q2
$1.99M Buy
12,236
+159
+1% +$28.5K 0.48% 54
2020
Q1
$2.09M Sell
12,077
-117
-1% -$23.3K 0.63% 45
2019
Q4
$2.45M Buy
12,194
+986
+9% +$202K 0.58% 45
2019
Q3
$2.37M Sell
11,208
-200
-2% -$41.8K 0.58% 47
2019
Q2
$2.21M Sell
11,408
-405
-3% -$74.7K 0.53% 50
2019
Q1
$1.94M Sell
11,813
-175
-1% -$30.9K 0.47% 61
2018
Q4
$2.25M Sell
11,988
-1,227
-9% -$227K 0.63% 44
2018
Q3
$2.25M Sell
13,215
-219
-2% -$36.9K 0.55% 52
2018
Q2
$2.2M Sell
13,434
-523
-4% -$85.4K 0.49% 56
2018
Q1
$2.26M Sell
13,957
-716
-5% -$114K 0.51% 54
2017
Q4
$2.14M Buy
14,673
+100
+0.7% +$14.2K 0.46% 73
2017
Q3
$1.98M Sell
14,573
-52
-0.4% -$6.57K 0.53% 73
2017
Q2
$1.83M Buy
14,625
+887
+6% +$106K 0.5% 73
2017
Q1
$1.63M Buy
13,738
+3,966
+41% +$477K 0.44% 71
2016
Q4
$1.13M Buy
9,772
+1,072
+12% +$119K 0.35% 105
2016
Q3
$909K Sell
8,700
-398
-4% -$41.5K 0.37% 97
2016
Q2
$886K Buy
+9,098
New +$860K 0.35% 111

Other funds holding CME

Stanley-Laman Group's CME Position: Q2 2026 in Review

Stanley-Laman Group increased its CME Group (CME) stake by 11% in Q2 2026, buying an estimated $29.6K and bringing the position to 1,094 shares worth $242K. The position accounts for 0.02% of the portfolio, ranked #283.

Stanley-Laman Group first reported a position in CME in Q2 2016 and has held it in 23 quarters since. The position peaked at $2.45M in Q4 2019. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Stanley-Laman Group held 1,094 shares of CME Group worth $242K as of Q2 2026.
  • Stanley-Laman Group bought 107 CME Group shares in Q2 2026, an estimated $29.6K.
  • CME Group made up 0.02% of Stanley-Laman Group's portfolio in Q2 2026, its #283 holding.
  • Stanley-Laman Group first reported a position in CME Group in Q2 2016 and has held it in 23 quarters since.
  • Stanley-Laman Group's CME Group position peaked at $2.45M in Q4 2019.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Stanley-Laman Group's 13F filing for Q2 2026, filed 5 Aug 2026.